OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)
Shankar Siva, Alexander V. Louie, Rupesh Kotecha, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 1, pp. e18-e28
Closed Access | Times Cited: 34
Shankar Siva, Alexander V. Louie, Rupesh Kotecha, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 1, pp. e18-e28
Closed Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 3, pp. 308-316
Closed Access | Times Cited: 47
Shankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 3, pp. 308-316
Closed Access | Times Cited: 47
Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis
Ryan S. Huang, Ronald Chow, Ali Benour, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 2
Ryan S. Huang, Ronald Chow, Ali Benour, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 2
Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy
Benedikt M. Schaarschmidt, Sebastian Zensen, Claudia Kesch, et al.
European Radiology (2025) Vol. 35, Iss. 3, pp. 1723-1731
Open Access | Times Cited: 1
Benedikt M. Schaarschmidt, Sebastian Zensen, Claudia Kesch, et al.
European Radiology (2025) Vol. 35, Iss. 3, pp. 1723-1731
Open Access | Times Cited: 1
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
A Randomized trial of stereotactic body radiation therapy vs radiofrequency ablation for the treatment of small renal masses: A feasibility study (RADSTER)
Raees Cassim, Rahul Bansal, Braden Millan, et al.
Urology (2025)
Open Access
Raees Cassim, Rahul Bansal, Braden Millan, et al.
Urology (2025)
Open Access
Utilization of a stabilized hyaluronic acid spacer in SBRT for retroperitoneal cancers: A case series and dosimetric analysis
Shing Fung Lee, Nathanial Harris, Pui Lam Yip, et al.
Clinical and Translational Radiation Oncology (2025) Vol. 52, pp. 100943-100943
Open Access
Shing Fung Lee, Nathanial Harris, Pui Lam Yip, et al.
Clinical and Translational Radiation Oncology (2025) Vol. 52, pp. 100943-100943
Open Access
Adult Renal Cysts: When to Intervene?
M. Bain, Adib Rahman, Nicholas J. Rukin, et al.
Trends in Urology & Men s Health (2025) Vol. 16, Iss. 1
Open Access
M. Bain, Adib Rahman, Nicholas J. Rukin, et al.
Trends in Urology & Men s Health (2025) Vol. 16, Iss. 1
Open Access
Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic Review
Nora Sundahl, Laurence Albigès, Toni K. Choueiri, et al.
European Urology (2025)
Closed Access
Nora Sundahl, Laurence Albigès, Toni K. Choueiri, et al.
European Urology (2025)
Closed Access
‘BJUI Clinical Dilemma’: the incidental small renal mass in a solitary kidney
Bruce Gao, Pratik Kanabur, Riccardo Campi, et al.
BJU International (2025)
Open Access
Bruce Gao, Pratik Kanabur, Riccardo Campi, et al.
BJU International (2025)
Open Access
Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis
Ryan S. Huang, Ronald Chow, Pradnya Chopade, et al.
Radiotherapy and Oncology (2024) Vol. 194, pp. 110216-110216
Open Access | Times Cited: 3
Ryan S. Huang, Ronald Chow, Pradnya Chopade, et al.
Radiotherapy and Oncology (2024) Vol. 194, pp. 110216-110216
Open Access | Times Cited: 3
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: a review on behalf of the CC AFU
Rita Bentahila, Karim Bensalah, Nicolas Benziane-Ouaritini, et al.
Deleted Journal (2024) Vol. 34, Iss. 7-8, pp. 102660-102660
Closed Access | Times Cited: 2
Rita Bentahila, Karim Bensalah, Nicolas Benziane-Ouaritini, et al.
Deleted Journal (2024) Vol. 34, Iss. 7-8, pp. 102660-102660
Closed Access | Times Cited: 2
Stereotactic ablative radiotherapy for primary kidney cancer – Authors' reply
Shankar Siva, Daniel Moon, David Pryor
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e230-e230
Closed Access | Times Cited: 1
Shankar Siva, Daniel Moon, David Pryor
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e230-e230
Closed Access | Times Cited: 1
Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide
Andrew B. Barbour, Rituraj Upadhyay, A. Anderson, et al.
Practical Radiation Oncology (2024)
Closed Access | Times Cited: 1
Andrew B. Barbour, Rituraj Upadhyay, A. Anderson, et al.
Practical Radiation Oncology (2024)
Closed Access | Times Cited: 1
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer
Muhammad Ali, Young Suk Kwon, Kendrick Koo, et al.
BJU International (2024) Vol. 135, Iss. 1, pp. 110-116
Open Access | Times Cited: 1
Muhammad Ali, Young Suk Kwon, Kendrick Koo, et al.
BJU International (2024) Vol. 135, Iss. 1, pp. 110-116
Open Access | Times Cited: 1
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting
Stephanie Berg, Salvatore La Rosa, Tian Zhang, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Open Access | Times Cited: 1
Stephanie Berg, Salvatore La Rosa, Tian Zhang, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Open Access | Times Cited: 1
French AFU Cancer Committee Guidelines – Update 2024–2026: Management of kidney cancer
P. Bigot, Romain Boissier, Z. Khene, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102735-102735
Open Access | Times Cited: 1
P. Bigot, Romain Boissier, Z. Khene, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102735-102735
Open Access | Times Cited: 1
Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
Daniel X. Yang, Raquibul Hannan
The Lancet Oncology (2024) Vol. 25, Iss. 3, pp. 267-269
Closed Access
Daniel X. Yang, Raquibul Hannan
The Lancet Oncology (2024) Vol. 25, Iss. 3, pp. 267-269
Closed Access
Re: Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Non-randomised Phase 2 Trial
Aimin Jiang, Ying Liu, Chen Cai, et al.
European Urology (2024) Vol. 86, Iss. 2, pp. 188-189
Closed Access
Aimin Jiang, Ying Liu, Chen Cai, et al.
European Urology (2024) Vol. 86, Iss. 2, pp. 188-189
Closed Access
Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?
Daniel E. Rivas, Alejandro de la Torre‐Luque, Elena Moreno-Olmedo, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Open Access
Daniel E. Rivas, Alejandro de la Torre‐Luque, Elena Moreno-Olmedo, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Open Access
The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)
Elena Moreno-Olmedo, Ami Sabharwal, Prantik Das, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2678-2678
Open Access
Elena Moreno-Olmedo, Ami Sabharwal, Prantik Das, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2678-2678
Open Access
Durable Local Control With Preserved Renal Function for Stereotactic Body Radiotherapy in Cryoablation-Refractory Clear Cell Renal Carcinoma
Parker Heger, Keaton Rummel, John M. Watkins
Cureus (2024)
Open Access
Parker Heger, Keaton Rummel, John M. Watkins
Cureus (2024)
Open Access
Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making
Alessio Pecoraro, Giuseppe Dario Testa, Laura Marandino, et al.
European Urology Oncology (2024)
Open Access
Alessio Pecoraro, Giuseppe Dario Testa, Laura Marandino, et al.
European Urology Oncology (2024)
Open Access
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Agata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3276-3276
Open Access
Agata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3276-3276
Open Access
Room for improvement when approaching RCC in the solitary kidney: surgery is not the only choice
Rohann Correa, Alexander V. Louie, Shankar Siva
European Urology Oncology (2024)
Closed Access
Rohann Correa, Alexander V. Louie, Shankar Siva
European Urology Oncology (2024)
Closed Access
Stereotactic Body Radiotherapy for Renal Cell Carcinoma—A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings
Conrad J. Villafuerte, Anand Swaminath
Cancers (2024) Vol. 16, Iss. 19, pp. 3334-3334
Open Access
Conrad J. Villafuerte, Anand Swaminath
Cancers (2024) Vol. 16, Iss. 19, pp. 3334-3334
Open Access
